24 February 2023 in IUCrJ
The transformation processes of non-solvated ibrutinib into a series of halogenated benzene solvates are explored in detail here. The transformation was studied in real time by X-ray powder diffraction in a glass capillary. Crystal structures of chlorobenzene, bromobenzene and iodobenzene solvates are isostructural, whereas the structure of fluorobenzene solvate is different. Four different mechanisms for transformation were discovered despite the similarity in the chemical nature of the solvents and crystal structures of the solvates formed. These mechanisms include direct transformations and transformations with either a crystalline or an amorphous intermediate phase. The binding preference of each solvate in the crystal structure of the solvates was examined in competitive slurry experiments and further confirmed by interaction strength calculations. Overall, the presented system and online X-ray powder diffraction measurement provide unique insights into the formation of solvates.
18 September 2026 in The AAPS Journal
Coamorphous systems are gaining interest as an effective formulation strategy to improve the solubility and dissolution of poorly water-soluble drugs. This
15 August 2022 in Chemické listy
After the approval of the first therapeutic monoclonal antibodies and their successful introduction into therapy, a great future was expected for this class of drugs. This assumption has been fulfilled to a limited extent only, especially in the treatment of oncological problems, some autoimmune diseases and in the treatment of some rare diseases. On the other hand, a considerable progress has been made in the fields of oncology and autoimmune diseases by discovering protein kinases, and these small molecule drugs represent alternatives in the treatment of a range of such diseases. In this article, we have tried to shed light mainly on the role of small molecules in therapy, including problems connected with the development of this class of drugs. For many of them, their physico-chemical properties prevent using traditional formulation techniques and modern technologies must be applied. This paper summarizes the most commonly used approaches for increasing bioavailability, including both the prodrug approach and the use of various solid forms of the active ingredient in specific formulations available on the market. The article also provides examples of practical use of amorphous solid dispersions and modern trends, including the development of various types of lipid formulations.
30 April 2025 in ChemRxiv
This study investigates venetoclax solvates and their nonsolvated forms through desolvation. Seven solvates were prepared, and their structures were solved from single-crystal X-ray diffraction data. Among these, two are cavity solvates, while the remaining five are channel solvates, with three being isostructural. Desolvation experiments led to two solvent-free crystalline polymorphs of venetoclax, Forms A and B. Notably, the acetone solvate remained stable and did not convert to a nonsolvated form. Form B has a higher melting point and a faster intrinsic dissolution rate than Form A. Advanced computational tools, including Solvate Analyser and CSD-Particle, provided insights into crystal surface properties and desolvation behaviour. Properties such as lattice energy, molecular interaction energy, attachment energy, surface rugosity, and solvent arrangement within the crystal and on the surface were linked to solvate stability and subsequent transformation upon desolvation. A combination of FTIR, and 13C and 15N solid-state NMR spectroscopies showed that both short- and long-range molecular interactions and arrangements of venetoclax molecules in the desolvated forms closely resembled those in the parent solvates.